Zydus Lifesciences gets USFDA nod to begin Phase II clinical trial of ZYIL1 in Parkinson's disease patients Ruchika Sharma18 Dec 2023 12:30 PM ISTZydus has been granted an 'Orphan Drug Designation' by the US FDA for ZYIL1 in treatment of patients with CAPS, a rare auto-inflammatory disease.
Seizure drug: Zydus Lifesciences gets USFDA approval for Lacosamide tablets Ruchika Sharma16 Dec 2023 12:45 PM ISTThe product will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad.
Zydus Lifesciences bags USFDA nod for HIV-1 drug Darunavir Ruchika Sharma15 Dec 2023 3:00 PM ISTDarunavir must be -co-administered with Ritonavir and with other antiretroviral agents.
USFDA nod to Zydus Lifesciences cancer drug Cyclophosphamide Ruchika Sharma14 Dec 2023 3:24 PM ISTCyclophosphamide is a chemotherapy medication that slows the growth of cancer cells.
Zydus Lifesciences gets USFDA okay for acquired methemoglobinemia injection Methylene Blue Ruchika Sharma6 Dec 2023 3:30 PM ISTMethylene Blue Injection is an oxidation-reduction agent indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia.
Zydus Lifesciences US arm concludes asset transfer of CUTX-101 for Menkes disease from Cyprium Therapeutics Ruchika Sharma6 Dec 2023 1:30 PM ISTSentynl now assumes full responsibility for the development and commercialization of CUTX-101.
Zydus Lifesciences gets USFDA nod for heart failure drug Ivabradine Ruchika Sharma1 Dec 2023 2:36 PM ISTThe drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India.
Zydus Lifesciences wins USFDA nod for diabetes drug Zituvimet Ruchika Sharma6 Nov 2023 11:34 AM ISTThe approval of ZITUVIMET is based on research, development, regulatory, and manufacturing work performed by Zydus teams.
Zydus Lifesciences, Lupin to co-market Saroglitazar Mg for chronic liver diseases treatment in India Ruchika Sharma3 Nov 2023 3:30 PM ISTUnder the terms of this agreement, Lupin will have semi-exclusive rights to co-market the product in India under the brand name LINVAS.
Zydus, Guardant Health to co-promote Guardant360 portfolio of liquid, tissue biopsy tests across India, Nepal Ruchika Sharma2 Nov 2023 3:30 PM ISTGuardant360 is a minimally invasive liquid biopsy test that provides comprehensive genomic profiling of all solid tumours by analysing circulating...
Zydus Lifesciences buys LiqMeds Group for around Rs 689 crore Ruchika Sharma1 Nov 2023 4:45 PM ISTZydus will pay an upfront consideration of GBP 68 million (around Rs 689 crore) and yearly earn-outs until 2026 depending on achievement of certain...
Sun Pharma to now offer Desidustat, first oral treatment for CKD-associated anaemia in India under brand Rytstat Ruchika Sharma30 Oct 2023 12:50 PM ISTMumbai: Strengthening its position in the chronic kidney disease space, Sun pharma is now going to offer Desidustat, the first-of-its-kind oral...
